Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.32 CNY
567.26 M CNY
4.98 B CNY
945.69 M
About RENHE PHARMACY CO
Sector
CEO
Wu Jun Huang
Headquarters
Nanchang
Website
Founded
1996
ISIN
CNE000000NF8
FIGI
BBG000P6CLY1
Renhe Pharmacy Co., Ltd. engages in the pharmaceutical business. It focuses on the production and sale of capsules, granules, pills, tablets, powder, injection, suppository, ointment, other Chinese and Western medicines, and health-related products. Its business scope includes Chinese herbal medicine planting; cultivation of medicinal seedlings; carton production and sale; computer software development; design, production, publishing, and domestic agents of advertising; building materials, machinery and equipment, electronic products, chemical products, metal materials, sports and office supplies, department stores wholesale and retail; and technical services and consulting. The company was founded on December 4, 1996 and is headquartered in Nanchang, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 000650 is 6.08 CNY — it has decreased by −2.07% in the past 24 hours. Watch RENHE PHARMACY CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange RENHE PHARMACY CO stocks are traded under the ticker 000650.
000650 stock has risen by 5.14% compared to the previous week, the month change is a 3.37% rise, over the last year RENHE PHARMACY CO has showed a −15.32% decrease.
000650 reached its all-time high on Jun 11, 2015 with the price of 17.28 CNY, and its all-time low was 0.20 CNY and was reached on Apr 25, 2006. View more price dynamics on 000650 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
000650 stock is 1.65% volatile and has beta coefficient of 1.21. Track RENHE PHARMACY CO stock price on the chart and check out the list of the most volatile stocks — is RENHE PHARMACY CO there?
Today RENHE PHARMACY CO has the market capitalization of 8.68 B, it has increased by 4.33% over the last week.
Yes, you can track RENHE PHARMACY CO financials in yearly and quarterly reports right on TradingView.
RENHE PHARMACY CO is going to release the next earnings report on Apr 25, 2025. Keep track of upcoming events with our Earnings Calendar.
000650 net income for the last quarter is 78.50 M CNY, while the quarter before that showed 159.88 M CNY of net income which accounts for −50.90% change. Track more RENHE PHARMACY CO financial stats to get the full picture.
Yes, 000650 dividends are paid annually. The last dividend per share was 0.20 CNY. As of today, Dividend Yield (TTM)% is 3.19%. Tracking RENHE PHARMACY CO dividends might help you take more informed decisions.
RENHE PHARMACY CO dividend yield was 3.02% in 2023, and payout ratio reached 49.04%. The year before the numbers were 3.23% and 48.74% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 14, 2024, the company has 5.79 K employees. See our rating of the largest employees — is RENHE PHARMACY CO on this list?
Like other stocks, 000650 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RENHE PHARMACY CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RENHE PHARMACY CO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RENHE PHARMACY CO stock shows the sell signal. See more of RENHE PHARMACY CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.